<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105239">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01734434</url>
  </required_header>
  <id_info>
    <org_study_id>V98_15OB</org_study_id>
    <nct_id>NCT01734434</nct_id>
  </id_info>
  <brief_title>Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems</brief_title>
  <official_title>A Multicenter, Observational Study to Identify Factors That Influence Access of Pregnant Women and Their Infants to Their Local Healthcare Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Vaccines</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will collect information regarding the factors that might influence access of
      pregnant women to the local healthcare system. The main visits of the study will be
      screening &amp; enrollment, delivery and 90 day infant follow-up. Data will be collected mainly
      from questionnaires administered to pregnant women at these visits. The questionnaires
      contain the following standard questions which will be asked at each visit, in addition to
      some visit-specific questions related to delivery and health status of infants up to 90 days
      of age. The standard questions will be related to the following aspects:

        -  Logistics of transportation to the study site (type, time it takes, cost incurred)

        -  Accessibility to a telephone/cell phone

        -  Provisions of alternative child care during site visits if there are other children
           under the subject's care
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify factors that might influence if a pregnant woman</measure>
    <time_frame>24 weeks or more of gestation</time_frame>
    <description>Identify factors that might influence if a pregnant woman:
will enroll in this study
will return to a study site to deliver
will seek medical attention for her sick infant at a study site
will bring her infant back to a study site for a follow-up visit at 90 days of age</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3257</enrollment>
  <condition>Pregnancy, Newborn Health</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <description>24 weeks or more of gestation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women of gestational age 24 weeks or more
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pregnant women with gestational age of greater than or equal to 24 weeks at the time
             of enrollment

          2. Subject / subject's parents or a legal representative who has given written consent
             after the nature of the study has been explained according to local regulatory
             requirements

          3. Pregnant women of gestational age between 28 weeks and 34 weeks 6/7 days

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Vaccines and Diagnostics</last_name>
    <role>Study Chair</role>
    <affiliation>Novartis Vaccines</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro Sanitario de Santo Domingo</name>
      <address>
        <city>Santo Domingo</city>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternidad Nuestra Senora de La Altagracia</name>
      <address>
        <city>Santo Domingo</city>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CISM Manhica Health Research Centre</name>
      <address>
        <city>Manhiça</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policentro Juan Diaz</name>
      <address>
        <city>Panama City</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policentro Parque Lefevre</name>
      <address>
        <city>Panama City</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlínica JJ Vallarino</name>
      <address>
        <city>Panama City</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Infectious Diseases Clinical Research Unit</name>
      <address>
        <city>Cape Town</city>
        <zip>7500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Setshaba Research Centre</name>
      <address>
        <city>Gauteng</city>
        <zip>0152</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Synexus Research Centre</name>
      <address>
        <city>Gauteng</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Respiratory and Meningeal Pathogens Research Unit</name>
      <address>
        <city>Soweto, Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Dominican Republic</country>
    <country>Mozambique</country>
    <country>Panama</country>
    <country>South Africa</country>
  </location_countries>
  <reference>
    <citation>WHO. Antenatal care in developing countries. Promises, achievements and missed opportunities. An analysis of trends, levels and differentials, 1990-2001. Geneva: 2003.</citation>
  </reference>
  <reference>
    <citation>Assembly UNG. A world fit for children. Outcome document of the Special Session on Children. New York: 2002.</citation>
  </reference>
  <reference>
    <citation>Qazi SA, Stoll BJ. Neonatal sepsis: a major global public health challenge. Pediatr Infect Dis J. 2009 Jan;28(1 Suppl):S1-2. doi: 10.1097/INF.0b013e31819587a9.</citation>
    <PMID>19106756</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <lastchanged_date>February 24, 2015</lastchanged_date>
  <firstreceived_date>November 22, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Health care access, Pregnant women</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
